Navigation Links
CareFusion To Acquire Vital Signs Division of GE Healthcare For $500 Million
Date:11/18/2013

SAN DIEGO, Nov. 18, 2013 /PRNewswire/ -- CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today announced the signing of a definitive agreement for CareFusion to acquire the Vital Signs division of GE Healthcare for $500 million.

With annual revenue of approximately $250 million, Vital Signs is a leading manufacturer of single-patient-use consumables for respiratory care and anesthesiology. The company also markets products for temperature management and patient monitoring consumables.

The acquisition will significantly expand CareFusion's Specialty Disposables business by adding global scale and new products for anesthesiology, establishing the company as a leader in the more than $3 billion market for respiratory and anesthesia consumables.

"The acquisition of Vital Signs is well-aligned to our long-term growth strategy, helping us create scale in our Procedural Solutions call points and increase our presence outside of the United States," said Kieran T. Gallahue, chairman and CEO of CareFusion. "Together, CareFusion and Vital Signs have the R&D, manufacturing and go-to-market resources to drive innovation, invest for growth and better support customers in major geographic markets."  

Strategic fit

With complementary product lines and geographies, the acquisition will enable CareFusion to:

  • Better serve customers globally: With approximately one-third of its revenue coming from customers outside the U.S., Vital Signs will advance CareFusion's goal to expand in international markets. The combined sales force will have deep customer and clinical expertise in major global markets.  
  • Accelerate the transformation of the Specialty Disposables busine
    '/>"/>

SOURCE CareFusion Corp.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. CareFusion Highlights Patient Safety, Actionable Data, Emergency Preparedness at American Association for Respiratory Care Congress
2. CareFusion Reports First Quarter Fiscal 2014 Results
3. Clinical Trials, New Orders, Improved Services, and Approvals - Research Report on CareFusion, St. Jude Medical, Community Health Systems, Neurocrine Biosciences, and Alnylam Pharmaceuticals
4. CareFusion Reports Fourth Quarter And Fiscal 2013 Results
5. Early Morning Insight: Baxter, CareFusion, Unilife, and Mindray Medical
6. FDA Approvals, Dividends, New Technologies, and Solid Margins Increase Shareholder Value - Research Report on Abbott, Baxter, CareFusion, Haemonetics, and CR Bard
7. CareFusion To Report Fourth Quarter And Fiscal 2013 Results On Aug. 8
8. 14 Additional Hospitals Select CareFusion Pyxis ES Platform To Improve Medication Management Efficiency, Safety
9. MD Anderson Signs Contract For Pyxis ES Technology From CareFusion
10. CareFusion Reports Third Quarter Fiscal 2013 Results
11. CareFusion Reaches Agreement In Principle On Previously Disclosed Matter With Federal Government
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2015  The report on breast cancer therapeutics: pipeline ... drugs on the basis of the molecules which are ... inner lining of milk ducts or lobules responsible for ... tumor that can spread to other cells present in ... lobules is referred as lobular carcinoma, while the other ...
(Date:9/2/2015)... The quantum dot market report analyzes the ecosystem of the ... product includes medical devices, display, and others. The others segment ... storage, QD laser, and transistor. The application segment covers the ... The report also provides the geographic view for major regions ... Europe , Asia-Pacific (APAC), and ...
(Date:9/2/2015)... NEW YORK , Sept. 2, 2015 /PRNewswire/ ... dystrophy is an X-linked disease, which generally affects ... muscle degeneration and weakness. The disease is caused ... result in the lack of production of dystrophin ... in individuals. The lack of dystrophin weakens muscle ...
Breaking Medicine Technology:Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 2Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023 3Quantum Dot Market by Product , Material, Application, and Geography- Forecast up to 2020 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 2Global Duchenne Muscular Dystrophy Drugs Market 2015-2019 3
... (Nasdaq: ALTH ) today announced the initiation ... multi-center dose,escalation study of the Company,s targeted chemotherapeutic ... non-Hodgkin,s lymphoma (NHL). "We are pleased to ... Cagnoni, M.D., Chief Medical Officer of Allos. "RH1 ...
... Appropriate Patient Selection Criteria for Future Field ... ... Corporation (Nasdaq: DVAX ) presented yesterday a detailed,analysis of data ... for ragweed allergic rhinitis. The,data were reported yesterday at the annual ...
Cached Medicine Technology:Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 2Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 3Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma 4Dynavax Presents New Analysis of TOLAMBA(TM) Data at ACAAI Meeting 2Dynavax Presents New Analysis of TOLAMBA(TM) Data at ACAAI Meeting 3
(Date:9/2/2015)... ... , ... The CRISPR-Cas9 system introduces double-strand DNA breaks at a ... either a chimeric single guide RNA (sgRNA) or two short RNAs (a CRISPR RNA ... or crRNA) to create a break in the target DNA that causes functional protein ...
(Date:9/2/2015)... ... September 02, 2015 , ... Healthegy, a leading ... two leaders who will deliver keynote presentations at the upcoming Digital Healthcare Innovation ... Hotel in Boston. , Larry Renfro, CEO of Optum, will deliver the morning ...
(Date:9/2/2015)... Washington, DC (PRWEB) , ... September 02, 2015 , ... ... company, American Well Corp., contracted to handle the telehealth services of more than 12 ... Blue Cross and Blue Shield Plans takes a look this growing trend, interviewing executives ...
(Date:9/2/2015)... ... ... Date and time: Oct. 3, 2015, 9 a.m. to 4 p.m. ... Athyn, Pa 19009 , Cost: $50 per person; includes lunch , The Quakertown, Pa.-based ... Sam Keen based on his new book which he co-authored with his son, Gifford ...
(Date:9/2/2015)... ... 2015 , ... RxNT , an innovative software solutions ... cloud-based mobile ePrescribing application. The release of this enhanced iPhone app marks the ... in health technology, RxNT was one of the first to build an ePrescribing ...
Breaking Medicine News(10 mins):Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 2Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 3Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 4Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 2Health News:Larry Renfro, CEO of Optum and Jonathan Bush, CEO of AthenaHealth to Address Healthcare Entrepreneurs and Investors at 5th Annual Digital Healthcare Innovation Summit 3Health News:AIS Newsletter Focuses on Growing Telehealth Trend Among Blues Plans 2Health News:AIS Newsletter Focuses on Growing Telehealth Trend Among Blues Plans 3Health News:justCommunity, Inc. and Bryn Athyn Men’s Groups Present Workshop on Family Reconciliation 2Health News:RxNT Releases Enhanced ePrescribing iPhone App to Improve Prescriber Usability 2
... decision making on issues whose consequences will only be ... annual Addiction Science Awards at this year,s Intel International ... science competition for high school students. The Intel ISEF ... Thursday night in Los Angeles. The awards were presented ...
... best efforts of scientists, in many cases the underlying causes of ... team of Australian and Swedish researchers, however, will go a long ... published in Science this week, a small set of ... are crucial to unravelling the secrets of male infertility. ...
... , THURSDAY, May 12 (HealthDay News) -- Representatives ... that she entered a facility for surgery to remove ... that can occur on the meninges, the brain,s protective ... who has been monitoring this for years, and a ...
... HealthDay Reporter , FRIDAY, May 13 (HealthDay News) -- Every ... to hungry students in the fourth-largest school district in the ... food and menu management for the Miami-Dade County Public Schools, ... that goal. The move by the U.S. Department of ...
... levels of cardiac troponin T (cTnT) or I (cTnI) ... of all-cause mortality and long-term adverse events such as ... nonemergent percutaneous coronary intervention (PCI) could improve long-term outcomes ... online in Catheterization and Cardiovascular Interventions , a ...
... This press release is available in French . ... it,s definitely going on., A recent survey, led by McGill ... reports that one in five respondents physicians and psychiatrists ... placebo. Moreover, an even higher proportion of psychiatrists (more than ...
Cached Medicine News:Health News:Altruistic decision making focus of NIDA's Addiction Science Award 2Health News:Altruistic decision making focus of NIDA's Addiction Science Award 3Health News:Research breakthrough on male infertility 2Health News:Brain Surgery for Mary Tyler Moore to Remove Benign Tumor 2Health News:School Systems Struggle With Lunchroom Costs 2Health News:Elevated protein levels in cardiac muscles could predict mortality following angioplasty 2Health News:The power of placebos 2
The Mid Field 30° lens has a bi-concave design to provide a wider field of view with a 30 degree offset image....
... The Chalam 30° Prism are ... and are recommended for tractional ... and Rhegmatogenus retinal detachment. They ... photocoagulation and other midperipheral laser ...
... Prism are designed for midperipherical ... for tractional retinal detachments (PDR, ... detachment. They can be used ... midperipheral laser applications. Direct image ...
... With somewhat higher magnification and increased ... suited for detailed visualization to the equatorial ... vitrectomy in diabetics and in membrane peeling ... (ACS) AutoClave Sterilizable Lenses The ACS Vitrectomy ...
Medicine Products: